The Sterile 20-like Kinase Tao-1 Controls Tissue Growth by Regulating the Salvador-Warts-Hippo Pathway  by Poon, Carole L.C. et al.
Developmental Cell
ArticleThe Sterile 20-like Kinase Tao-1
Controls Tissue Growth by Regulating
the Salvador-Warts-Hippo Pathway
Carole L.C. Poon,1 Jane I. Lin,1,3 Xiaomeng Zhang,1,2,3 and Kieran F. Harvey1,2,*
1Cell Growth and Proliferation Laboratory, Peter MacCallum Cancer Centre, 7 St. Andrews Place, East Melbourne, Victoria 3002, Australia
2Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia
3These authors contributed equally to this work
*Correspondence: kieran.harvey@petermac.org
DOI 10.1016/j.devcel.2011.09.012SUMMARY
The Salvador-Warts-Hippo (SWH) pathway is
a complex signaling network that controls both
developmental and regenerative tissue growth.
Using a genetic screen in Drosophila melanogaster,
we identified the sterile 20-like kinase, Tao-1, as an
SWH pathway member. Tao-1 controls various bio-
logical phenomena, includingmicrotubule dynamics,
animal behavior, and brain development. Here we
describe a role for Tao-1 as a regulator of epithelial
tissue growth that modulates activity of the core
SWH pathway kinase cassette. Tao-1 functions
together with Hippo to activate Warts-mediated
repression of Yorkie. Tao-1’s ability to control SWH
pathway activity is evolutionarily conserved because
human TAO1 can suppress activity of the Yorkie
ortholog, YAP. Human TAO1 controls SWH pathway
activity by phosphorylating, and activating, the
Hippo ortholog, MST2. Given that SWH pathway
activity is subverted in many human cancers, our
findings identify human TAO kinases as potential
tumor suppressor genes.
INTRODUCTION
The Salvador-Warts-Hippo (SWH) pathway is a conserved regu-
lator of tissue growth (Harvey and Tapon, 2007). SWH pathway
activity is frequently subverted in human malignancies and
therefore is often referred to as a tumor suppressor pathway
(Harvey and Tapon, 2007; Zeng and Hong, 2008). More than
20 proteins have been designated as members of the SWH
pathway in Drosophila melanogaster. These can be broadly
grouped into three classes: upstream regulators, the core kinase
cassette, and downstream transcription regulators (Grusche
et al., 2010; Harvey and Tapon, 2007; Oh and Irvine, 2010).
Likemany signaling pathways, phosphorylation plays a central
role in SWH pathway signal transduction. Thus far, four kinases
have been identified as regulators of the SWH pathway, each of
which is a Serine/Threonine (S/T) kinase: Hippo (Hpo) and Warts
(Wts) are members of the core kinase cassette (Harvey et al.,896 Developmental Cell 21, 896–906, November 15, 2011 ª2011 Els2003; Jia et al., 2003; Pantalacci et al., 2003; Tapon et al.,
2002; Udan et al., 2003; Wu et al., 2003), whereas Discs over-
grown (Dco) and Four-jointed (Fj) function in the upstream Fat/
Dachsous (Ft/Ds) branch of the SWH pathway (Grusche et al.,
2010). Hpo phosphorylates and activates other members of
the core kinase cassette; Salvador (Sav), Mob as tumor
suppressor (Mats), and Wts (Pantalacci et al., 2003; Wei et al.,
2007; Wu et al., 2003), whereas Wts phosphorylates the key
progrowth protein of the SWH pathway, Yki (Dong et al., 2007;
Oh and Irvine, 2008, 2009). Yki is a critical target of Wts because
overexpression of Yki mimics the strong overgrowth observed
when sav, hpo, mats, or wts is mutated (Huang et al., 2005).
Wts-mediated phosphorylation inhibits Yki activity by tethering
it in the cytoplasm, which limits its ability to complex with its
cognate transcription factors, such as Scalloped (Sd), and thus
prevents expression of genes that promote cell viability, prolifer-
ation, and growth (Dong et al., 2007; Oh and Irvine, 2008; Zhao
et al., 2007).
Several recent studies have suggested that protein phosphor-
ylation events other than those described here play an important
role in SWH pathway signal transduction. Most notably, two
studies assessed proteome-wide phosphorylation events on
S, T, and Tyrosine (Y) residues in D. melanogaster embryos or
Kc167 cultured cells and identified approximately 50 phosphor-
ylation events on known SWH pathway proteins, many more
than have been identified by other means (Bodenmiller et al.,
2007; Zhai et al., 2008). Although the validity of each phosphor-
ylation event has not been determined, many were classified as
‘‘high confidence’’ events and were independently identified in
both studies (Bodenmiller et al., 2007; Zhai et al., 2008). The
predicted target specificity of known SWH pathway kinases,
Dco, Fj, Hpo, and Wts, and genetic epistasis experiments
suggest that unidentified SWH pathway kinases are responsible
for at least some of these phosphorylation events. Genetic
evidence has also hinted at the existence of undefined phos-
phorylation-dependent regulation of SWH pathway proteins.
Phosphorylation of two Yki resides (S169 and S172) were
proposed to be required for optimal growth-promoting activity
of Yki, but the responsible kinase(s) was not identified (Oh and
Irvine, 2009), whereas kinases other than Dco were implicated
in phosphorylation of the cytoplasmic domain of Fat (Feng and
Irvine, 2009; Sopko et al., 2009). In addition, studies in mouse
embryonic fibroblasts (MEFs) and the mouse liver implicated
unknown kinases in the control of YAP activity. In liver, the Hpoevier Inc.
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the Wts kinase orthologs, LATS1/2, whereas the reverse situa-
tionwas reported inMEFs (Zhou et al., 2009). In addition, kinases
other than MST1/2 and LATS1/2 were hypothesized to phos-
phorylate YAP in adult mouse skin (Schlegelmilch et al., 2011).
To identify SWH pathway protein kinases, we conducted
a genetic screen in D. melanogaster and identified Tao-1 as
one such candidate. Tao-1 kinase belongs to the diverse sterile
20-like family and has been implicated in regulation of apoptosis,
microtubule dynamics, behavior, and brain development
(King et al., 2011; Liu et al., 2010; Sato et al., 2007). Tao-1
deficiency led to increases in the size of D. melanogaster organs
and hyperactivation of the progrowth protein, Yki, whereas
Tao-1 overexpression limited organ size and Yki activity. Genetic
epistasis and biochemical experiments show that Tao-1
functions upstream of Hpo to activate the Wts kinase. This
function of Tao-1 is evolutionarily conserved because its closest
mammalian homolog, TAO1, can suppress activity of the
Yki ortholog, YAP, and phosphorylate and activate the Hpo
ortholog, MST2.
RESULTS
To discover SWH pathway-regulatory kinases, we performed an
in vivo D. melanogaster RNAi screen. A yki transgenic line
(YkiS168A-YFP) was engineered such that overexpression by
the GMR promoter (which is active in differentiating cells of the
larval eye) caused a partial increase in eye size, providing an
ideal sensitized screening phenotype (Zhang et al., 2009). The
utility of this strain was verified by crossing it to RNAi lines
specific to SWH pathway genes that either enhanced (e.g.,
wts, hpo, or mats) or suppressed (e.g., sd), as expected, the
extent of tissue growth observed in the GMR-YkiS168A-YFP
eye (data not shown). This strain was crossed individually to
UAS-RNAi lines directed against the 251 kinases predicted to
be encoded by the D. melanogaster genome (Morrison et al.,
2000). A strong positive hit from this screen was Tao-1, which
when knocked down, increased overgrowth of GMR-
YkiS168A-YFP eyes (see Figures S1A–S1C available online).
Importantly, this result was validated using two independent
RNAi lines directed against separate regions of the Tao-1
gene, showing that this phenotype was caused by depletion of
Tao-1 and not due to off-target effects (Figure S1D; data not
shown). A signature phenotype of SWH pathway repression is
an increase in interommatidial cells (IOCs) that survive a wave
of apoptosis during the mid-pupal phase of development (Tapon
et al., 2002). As expected, GMR-Gal4-dependent expression of
UAS-YkiS168A-YFP caused an increase in IOC number in eyes
that were dissected 44 hr after puparium formation (APF)
(Figures S1A0 and S1B0). Expression of UAS-Tao-1 RNAi trans-
genes together with UAS-YkiS168A-YFP further increased IOC
number, suggesting that Yki activity was enhanced upon Tao-1
depletion (Figures S1C0 and S1D0).
Tao-1 Regulates the Growth of D. melanogaster Tissues
To further investigate a role for Tao-1 in regulation of organ size,
we modulated Tao-1 expression using RNAi or overexpression
transgenes in developing D. melanogaster eye and wing tissues.
RNAi-mediated depletion of Tao-1 using the GMR-Gal4 driverDevelopmegave rise to slightly larger eyes, particularly in the posterior
region of the eye (arrowhead, Figure 1B) compared with the
driver alone (Figure 1A). This increase in eye size was due to
specific knockdown of Tao-1 because coexpression of Tao-1
(using the EP element insertion, Tao1EP1455) with UAS-Tao-1
RNAi using GMR-Gal4 reverted the overgrowth phenotype
(Figure 1C). Furthermore, expression of the Tao-1 RNAi trans-
gene in imaginal discs caused substantial depletion of Tao-1
protein (Figure S1J).
By performing BrdU incorporation assays, we showed that
when Tao-1 was depleted in third-instar larval eye discs, cells
posterior to the second mitotic wave that are normally quiescent
reentered the cell cycle (Figures S1G and S1H). In addition,
analysis of the cellular architecture of GMR-Gal4, Tao-1 RNAi
pupal retinae 44 hr APF showed an increase in IOCs (Figure 1E)
compared with the control (Figure 1D). Both of these phenotypes
are characteristic features of Yki hyperactivation. To analyze the
effect of depleting Tao-1 in the developing eye-antennal disc
earlier in development, we used the eyeless (ey)-FLP-MARCM
system to drive expression of the UAS-Tao-1 RNAi transgene
from the commencement of eye-antennal development (Lee
and Luo, 1999). Consistent with a role for Tao-1 in repressing
tissue growth, the overall size of heads from flies that expressed
the UAS-Tao-1 RNAi transgene in developing eye-antennal
discs was increased compared with the FRT82B control. Extra
head cuticle was obvious between the eyes, and the eyes them-
selves were convoluted (Figures S1E and S1F).
Expression of UAS-Tao-1 RNAi transgenes in developing
wings using Gal4 lines at 25C such as engrailed (en), hedgehog
(hh), 32B, or apterous caused organism lethality during pupal
development (data not shown). Expression of UAS-Tao-1 RNAi
with the 71B-Gal4wing driver at 25Cproduced adults; however,
the overgrown and crumpled wing phenotype precluded
accurate measurement of adult wing size (data not shown).
When shifted to 18C, to reduce transgene expression, Tao-1
depletion caused a 7% increase in size relative to control wings
(Figures 1F–1H). To analyze a role for Tao-1 in control of wing
size further, we overexpressed a UAS-inducible Flag epitope-
tagged Tao-1 transgene (herein referred to as UAS-Tao-1) in
the posterior compartment of the developing wing using
hh-Gal4. Tao-1 overexpression caused a 14% reduction of the
posterior compartment size of the wing compared to control
wings expressing aUAS-LacZ transgene. This effect was depen-
dent on Tao-1’s kinase activity because expression of a kinase-
dead Tao-1 transgene, containing a missense mutation (D168A)
in the activation loop of the kinase domain (Sato et al., 2007),
failed to reduce wing size (Figures 1I–1K). Tao-1 overexpression
using rotund-Gal4 also reduced wing size and caused wing
scalloping, a phenotype observed upon reduction of activity of
the SWH pathway proteins, Sd and Wbp2 (Figure S1L) (Zhang
et al., 2011).
To further investigate a role for Tao-1 in control of organ size,
we assessed the size of wings from Tao-1 hypomorphic animals
that were transheterozygous for two Tao-1 alleles: Tao150, a null
deletion allele, and Tao-1EP1455, which causes a partial reduction
in Tao-1 protein (King et al., 2011). Tao-1 hypomorphic flies ap-
peared relatively normal, although wings from these flies were,
on average, 8% larger than control flies (Tao-1 EP1455/FM6k)
(Figures 1L–1N). Collectively, these results show that the growthntal Cell 21, 896–906, November 15, 2011 ª2011 Elsevier Inc. 897
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Figure 1. Modulation of Tao-1 Levels Affects Organ Size
(A–C) Adult female D. melanogaster eyes; anterior is to the left.
(D and E) D. melanogaster eyes 44 hr APF stained with anti-Discs-large.
Scale bar represents 10 mM. Eyes express the following elements under the
control of GMR-Gal4: (A) and (D) UAS-LacZ; (B) and (E) UAS-Tao-1 RNAi KK;
(C) UAS-Tao-1 RNAi KK and Tao-1EP1455.
(F, G, I, J, L and M) Adult female D. melanogaster wings; anterior is to the left.
(F) 71B-Gal4, UAS-GFP.
(G) 71B-Gal4, UAS-Tao1 RNAi GD.
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898 Developmental Cell 21, 896–906, November 15, 2011 ª2011 Elsof D. melanogaster eyes and wings is sensitive to Tao-1 levels
and suggests that the Tao-1 kinase regulates organ size during
development.
Tao-1 Regulates SWH Pathway Activity
Next, we sought to determine whether Tao-1 regulates organ
size by modulating activity of the SWH pathway. We hypothe-
sized that if this were true, Tao-1 depletion would cause hyper-
activation of the key downstream SWH pathway protein, Yki.
When Tao-1 was knocked down in developing wing imaginal
discs using hh-Gal4, strong elevation of Yki activity, as deter-
mined by an increase in ex-lacZ levels, was observed (Figures
2B and 2B0) compared with control wing discs (Figure 2A). In
concordance with this finding, another Yki target gene, ban
microRNA, was elevated upon Tao-1 knockdown using en-Gal4,
as revealed by a reduction in the ban-GFP sensor (Figures 2D
and 2D0) compared with control wing discs (Figure 2C). ban
levels were elevated throughout the posterior wing disc, whereas
increases in ex transcription were most obvious in the wing
pouch. We are unsure of the reason for this discrepancy that
has not been reported for members of the core SWH pathway
kinase cassette.
As an independent readout of Yki activity, we assessed ex
levels by quantitative RT-PCR on RNA extracted from third-
instar larval eye and wing imaginal discs, or whole larvae of the
following genotypes: w1118, Tao-1 EP1455/Tao-1 50, or wtsP2
(as a positive control). In each tissue preparation, we observed
a 2-fold increase in ex mRNA in Tao-1 hypomorphs compared
to the w1118 control, and as expected, ex levels were strongly
elevated in wts samples (Figure 2E). We also analyzed expres-
sion of Ex protein when Tao-1 was depleted in a sensitized
genetic background. In clones of tissue that expressed the
UAS-Tao-1 RNAi transgene or that were hypomorphic for a
weak allele of sav (sav2) (Tapon et al., 2002), we observed
minimal elevation of Ex. However, when both Tao-1 and Sav
function were compromised together, strong elevation of Ex
was observed, indicating that loss of Tao-1 contributes to strong
Yki hyperactivation (Figures S2A–S2C00).
We also used genetic studies to examine whether Tao-1
modulates tissue growth via the SWH pathway. Overexpression
of the Fat cytoplasmic domain retards tissue growth (Matakatsu
and Blair, 2006), whereas RNAi-mediated depletion of Hpo or
Kibra causes overgrowth (Genevet et al., 2010; Pantalacci
et al., 2003). When the Tao50 allele was introduced into these
genetic backgrounds, significant increases in wing size were
observed in each scenario (Figures 2F and 2G). In a different(H) Quantification of the total wing area of the indicated genotypes. n = 13 in (F)
and 9 in (G).
(I and J) Posterior compartments are false-colored purple. n = 21 in (I) and 15
in (J).
(I) hh-Gal4, UAS-Tao-1.
(J) hh-Gal4, UAS-Tao-1 D168A.
(K) Quantification of the posterior compartment of wings of the indicated
genotypes.
(L) Tao-1 EP1455/FM6k.
(M) Tao-1 EP1455/Tao-150. n = 30 in both (L) and (M).
(N) Quantification of the total wing area of the indicated genotypes.
In (H), (K), and (N), results represent mean ± SEM. ***p < 0.001. See also
Figure S1.
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Figure 2. Tao-1 Regulates SWH Pathway Activity
(A–D0)D. melanogaster third-instar larval wing imaginal discs of the following genotypes: (A) ex-lacZ; hh-Gal4/UAS-GFP, (B and B0) ex-lacZ/UAS-Tao-1 RNAi KK;
hh-Gal4, (C) en-Gal4; ban-GFP, and (D and D0) en-Gal4; UAS-Tao-1 RNAi KK/ban-GFP. Scale bars represent 100 mM. Transcriptional activity of the ex gene is
reported by detecting b-galactosidase expression (gray in A and B, and green in the merged image, B0), and activity of ban is negatively marked by the ban-GFP
sensor (gray in C and D, and green in the merged image, D0). Cubitus interruptus (Ci) expression negatively marks the expression domain, the anterior
compartment of the wing disc (red in merged images, B0 and D0 ).
(E) exmRNA relative to control actin5CmRNA in either third-instar larvae eye and wing imaginal discs or whole larvae of the indicated genotypes, as determined
by quantitative PCR. Results represent mean ± SD. ***p < 0.001.
(F andG) Quantification of wing area from female flies of the indicated genotypes whereUAS transgenes were driven by en-Gal4 (F) and 32B-Gal4 (G). (F) From left
to right, n = 22, 11, 23, and 14, and in (G) from left to right n = 19 and 20. Results represent mean ± SEM. ***p < 0.001.
(H) Luciferase assay measuring activity of a Yki-Gal4 fusion protein in D. melanogaster S2 cells expressing the indicated plasmids. wt, wild-type Tao-1; K56A,
Tao-1 with a mutation in the ATP-binding site; KD, Tao-1 with a deletion of residues 51–354 including the kinase domain; CD, Tao-1 with a deletion of residues
423–900 including the central domain; CCD, Tao-1 with a deletion of residues 900–1039 including the coiled coil domain (n = 3 in each sample). Results are
mean ± SEM. **p < 0.01 and ***p < 0.001. ns, not significant.
See also Figure S2.
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suppress tissue growth caused by depletion of SWH pathway
proteins, or of PTEN, a negative regulator of the Insulin pathway.
Tao-1 overexpression reduced wing overgrowth caused by
RNAi-mediated depletion of either Mer, Ex, Kibra, or Fat, or over-
expression of Dachs (Figures S2D–S2H0). By contrast, Tao-1
overexpression had no impact on wing overgrowth driven by
PTEN knockdown, showing that Tao-1’s ability to repress tissue
overgrowth is specific to the SWH pathway (Figures S2I and
S2I0). Collectively, these results provide further evidence that
Tao-1 controls tissue growth by regulating the SWH pathway.
In an independent attempt to establish whether Tao-1 could
regulate SWH pathway activity, we employed a Yki-Gal4 tran-
scription assay that gauges Yki’s transcriptional coactivatorDevelopmefunction (Huang et al., 2005). When overexpressed in S2 cells,
Yki-Gal4 increased transcription of a UAS-luciferase reporter
by approximately 7-fold (Figure 2H). To determine whether
Tao-1 could suppress Yki activity, we coexpressed Yki with
a series of copper-inducible Tao-1 vectors (Liu et al., 2010).
Wild-type Tao-1 reduced Yki activity by approximately 30%
(Figure 2H). Deletion of the coiled-coil domain or the kinase
domain of Tao-1 ablated the ability of Tao-1 to repress Yki, as
did a missense mutation in the ATP-binding site of Tao-1’s
kinase domain (K56A). By contrast, deletion of the central
domain of Tao-1 further increased Tao-1’s ability to repress
Yki (Figure 2H). These results show that Tao-1 relies on its kinase
domain to repress Yki, and suggest that the coiled-coil and
central domains are important in regulating Tao-1 activity.ntal Cell 21, 896–906, November 15, 2011 ª2011 Elsevier Inc. 899
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Figure 3. Tao-1 Enhances Activity of the Core SWH Pathway Kinase Cassette, and Its Function Is Conserved in Mammals
(A) Luciferase assay measuring activity of Yki-Gal4 in D. melanogaster S2 cells expressing the indicated plasmids.
(B–E) Adult femaleD.melanogaster eyes; anterior is to the left. Eyes express the following transgenes: (B)GMR-Gal4 andUAS-lacZ; (C)GMR-Gal4 andUAS-Tao-
1; (D) GMR-sav, GMR-wts, and GMR-Gal4; (E) GMR-sav, GMR-wts, GMR-Gal4, and UAS-Tao-1.
(F) Luciferase assay measuring the ability of YAP2 or hyperactivated YAP2 (5SA) to activate the TEAD2 transcription factor in 293T cells expressing the indicated
plasmids.
(G) Quantitation of alamarBlue-positive MCF10A cells transfected with either nontargeting siRNA (siNT) or TAO1 siRNA (siTAO1) that were grown in soft agar for
5 days. Data were normalized to the siNT control.
(H) To assess TAO1 and YAP knockdown, lysates from cells used in (G) were probed with antibodies to TAO1, YAP, and Tubulin.
In (A), n = 4, and in (F) and (G), n = 3. Results for each are mean ± SEM. **p < 0.01, ***p < 0.001.
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Pathway Kinase Cassette
To examine Tao-1’s ability to regulate Yki further, we investi-
gated potential relationships with the SWH pathway core kinase
cassette using luciferase assays. Coexpression of Yki with the
scaffold protein, Sav, and the downstream S/T kinase, Wts,
caused 60% reduction in Yki activity (Figure 3A). When Tao-1
was cotransfected with Yki, Sav, and Wts, Yki activity was
repressed almost back to control levels, showing that Tao-1
cooperates with Sav and Wts to repress Yki (Figure 3A). We
also explored these relationships in vivo. Expression of
a UAS-Tao-1 transgene with GMR-Gal4 in the developing
D. melanogaster eye did not obviously affect eye size (Fig-
ure 3C). When overexpressed under direct control of the GMR
promoter, hpo induces a small rough eye (Wu et al., 2003). Co-
overexpression of Tao-1 and hpo was lethal, and animals that
survived to the pharate adult stage exhibited eyes that were
smaller than eyes fromGMR-hpo alone (data not shown). A simi-
larly reduced eye phenotype, though less severe than that of900 Developmental Cell 21, 896–906, November 15, 2011 ª2011 ElsGMR-hpo, is observed upon overexpression of both sav and
wts under direct control of theGMR promoter (Figure 3D) (Tapon
et al., 2002). When combined with Tao-1 overexpression,
a further decrease in eye size was observed (Figure 3E). Further-
more, GMR-mediated coexpression of sav and wts with kinase-
dead Tao-1 abolished Tao-1’s ability to enhance the sav andwts
reduced eye phenotype, showing that kinase activity is required
for Tao-1 to collaborate with the core kinase cassette (data not
shown). These findings are consistent with our observations in
cultured cells and show that Tao-1 can cooperate with the
SWH pathway core kinase cassette to repress both Yki activity
and tissue size.
Tao-1’s Function as a Regulator of the SWH
Pathway Is Conserved in Mammals
Several elements of the SWH pathway are conserved in
mammals, and almost all Drosophila SWH pathway proteins
have mammalian orthologs. Genetic ablation of murine SWH
pathway tumor suppressor genes or overexpression of the Ykievier Inc.
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Tao-1 Regulates the SWH Pathwayortholog, YAP, causes overgrowth of tissues such as the liver,
gastrointestinal tract, and skin (Halder and Johnson, 2011).
The basic mechanism by which the SWH pathway transduces
signals by phosphorylation also appears to be conserved
between flies and mammals: MST1/2 phosphorylate and acti-
vate both the Wts (LATS1/2) and MATS orthologs (MOBKL1A/
1B), whereas LATS1/2 phosphorylate the Yki orthologs TAZ
and YAP at conserved sites, leading to complex formation with
14-3-3 proteins and cytoplasmic sequestration (Dong et al.,
2007; Oka et al., 2008; Praskova et al., 2008; Zhao et al., 2007).
Tao-1 has three human orthologs (TAO1, TAO2, and TAO3)
that each share the same set of domains and exhibit 49%,
36%, and 52% similarity to D. melanogaster Tao-1, respectively.
To examine whether Tao-1’s ability to regulate the SWHpathway
is conserved in mammals, we investigated TAO1. Initially, we
explored whether TAO1 could modulate YAP’s ability to activate
the TEAD2 transcription factor in a luciferase-based assay in
293T cells. When TAO1 was overexpressed together with YAP
(bar 3, Figure 3F), we found that it significantly suppressed
YAP activity by 45% (compare to bar 2, Figure 3F), consistent
with the ability of D. melanogaster Tao-1 to suppress Yki. Impor-
tantly, TAO1 was unable to suppress activity of YAP-5SA,
a mutant version of YAP that is impervious to LATS1/2-mediated
repression because it lacks five well-characterized LATS1/2
phosphorylation sites (bars 8–9, Figure 3F).
These results suggested that TAO1 represses YAP by acti-
vating the core kinase cassette of the SWH pathway. In
D. melanogaster, we showed that coexpression of Tao-1 with
Wts and Sav enhanced their ability to repress Yki. We discovered
a similar relationship between the mammalian orthologs of these
proteins. When cells overexpressed LATS1 and SAV1, YAP’s
ability to activate the TEAD transcription factor was repressed
by 40% (bar 4, Figure 3F). Addition of either TAO1 or MST2
to these cells shows similar repression of YAP (bars 5 and 6,
respectively, Figure 3F). Moreover, when TAO1 was additionally
expressed with the core kinase cassette proteins LATS1, SAV1,
and MST2, YAP activity was almost completely abolished
(compare bar 7 with bar 6, Figure 3F).
The mammalian SWH pathway is deregulated in many
different human cancers, and subversion of pathway activity
has oncogenic consequences in both mice and cell culture
models (Harvey and Tapon, 2007). The major tissue growth-
promoting gene of the SWH pathway, YAP, displays several
hallmarks of oncogenes including the ability to stimulate
anchorage-independent cell growth (Overholtzer et al., 2006;
Zhang et al., 2009). In addition, knockdown of genes that inhibit
YAP function, such as LATS1, can also induce anchorage-inde-
pendent growth (Zhang et al., 2008). To determine whether TAO1
possessed tumor suppressor properties in cultured cells, we
used siRNAs to deplete TAO1 expression in MCF10A cells, an
immortalized but nontransformed human mammary epithelial
cell line. TAO1 depletion caused a 1.7-fold increase in the ability
of cells to grow in an anchorage-independent fashion when
plated in soft agar, compared to cells transfected with control
nontargeting siRNAs (Figure 3G). To determine whether this
increase was likely due to elevated YAP activity, we treated
cells with YAP siRNA either alone or together with TAO1 siRNA.
Depletion of YAP in TAO1-depeleted cells completely reversed
their ability to grow in soft agar (Figure 3G). Immunoblot analysisDevelopmeof MCF10A cell lysates showed that siRNA-mediated reduction
of TAO1 and YAP proteins was efficient (Figure 3H). These
data support the notion that TAO1’s role as a regulator of the
SWH tumor suppressor pathway is conserved in humans.
Tao-1 Requires Wts and Hpo to Repress Yorkie Activity
To determine whether Tao-1 regulates Yki by acting on it directly
or indirectly via the SWH pathway core kinase cassette, we
initially used the Yki-Gal4 luciferase assay. Consistent with
previous data, Tao-1 overexpression repressed Yki activity by
40% compared to the control (bars 2 and 3, Figure 4A). To
determine whether the SWH pathway core kinase cassette
was required for Tao-1 to repress Yki, we overexpressed
Tao-1 in S2 cells that were treated with double-stranded RNA
(dsRNA) specific for wts. Knockdown of Wts completely sup-
pressed Tao-1’s ability to repress Yki activity (bar 5, Figure 4A).
To investigate this epistatic relationship further, we utilized
RNA interference in vivo. As shown in Figures 1A and 1B,
RNAi-mediated depletion of Tao-1 caused a subtle increase in
eye size compared to control eyes. GMR-Gal4-dependent over-
expression of UAS-wts caused a reduction in eye size (Fig-
ure 4B). Tao-1 was not required forwts overexpression to restrict
tissue size because Tao-1 depletion did not affect the size of
eyes overexpressing wts (Figure 4C). In addition, by using the
MARCM system, we found that Tao-1 RNAi failed to enhance
the size of clones of tissue null for wts (Figures S3A–S3D).
Collectively, these data show that Tao-1 acts upstream of Wts
to repress Yki, rather than acting directly on Yki itself.
By contrast, Tao-1 was required for the ability of Hpo to inhibit
eye growth because Tao-1 depletion almost completely reverted
the eye size reduction caused byGMR-dependent expression of
hpo (Figures 4D and 4E). This could infer that Tao-1 functions
downstream of Hpo, or that Hpo functions downstream of
Tao-1, where Tao-1 is required to activate Hpo, even when
Hpo is overexpressed. A precedent for this latter scenario has
been reported: Hpo is required for Sav and Wts to retard tissue
growth when overexpressed (Harvey et al., 2003), but biochem-
ical studies clearly show that Hpo functions upstream of Sav and
Wts (Wu et al., 2003). Therefore, to further investigate the
epistatic relationship between Hpo and Tao-1, we used the
MARCM system to determine whether Tao-1 depletion by
RNAi could enhance the size of null hpo clones. Compared to
the control, there was an increase in the percentage of total
clonal tissue in mosaic wing discs that either were null for hpo
or expressed UAS-Tao-1 RNAi. However, the percentage of
double mutant clonal tissue relative to total wing area was no
more increased than that of either single mutant (Figures S3E–
S3I), suggesting that Tao-1 and Hpo control tissue growth via
the same pathway and arguing against a model whereby Hpo
functions upstream of Tao-1.
Hpo Is Required for Tao-1 to Stimulate Wts Activity
Based on observations from genetic epistasis experiments, we
predicted that Tao-1 functions upstream of Hpo to limit tissue
growth and repress Yki activity. To interrogate this hypothesis,
we assessed whether Tao-1 could modulate phosphorylation
of Yki at residue S168, a key function of the Wts kinase that is
activated by Hpo (Dong et al., 2007). Overexpression of Tao-1
induced Yki-S168 phosphorylation, though not with the samental Cell 21, 896–906, November 15, 2011 ª2011 Elsevier Inc. 901
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Figure 4. Tao-1 Requires Wts and Hpo to Repress Yorkie Activity
(A) Luciferase assay measuring activity of a Yki-Gal4 fusion protein in S2 cells
transfected with the indicated plasmids and dsRNA (n = 3 in each sample).
Results are mean ± SEM. ***p < 0.001.
(B–E) Adult female D. melanogaster eyes; anterior is to the left. Eyes express
the following transgenes: (B) GMR-Gal4 and UAS-wts; (C) GMR-Gal4,
UAS-wts, and UAS-Tao-1 RNAi KK; (D) GMR-hpo and GMR-Gal4; (E) GMR-
hpo, GMR-Gal4, and UAS-Tao-1 RNAi KK.
See also Figure S3.
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Figure 5. Hpo Is Required for Tao-1 to Stimulate Wts Activity in S2
Cells
(A) Phospho-S168-Yki levels in S2 cells transfected with the indicated
plasmids and dsRNAs. Lysates were also probed with anti-HA to reveal Yki
and anti-Tubulin (Tub).
(B) Luciferase assay measuring activity of Yki-Gal4 fusion protein in S2 cells
expressing the indicated plasmids. Cells in some treatments were incubated
with dsRNA to hpo or Tao-1 (n = 3 in each sample). Results are mean ± SEM.
**p < 0.01.
See also Figure S4.
Developmental Cell
Tao-1 Regulates the SWH Pathwaypotency as Hpo overexpression, suggestive of increased Wts
activity (lanes 4 and 3, respectively, Figure 5A). When Tao-1
and Hpo were coexpressed, Yki-S168 phosphorylation was
enhanced (lane 5, Figure 5A). To examine the relationship
between Tao-1 and Hpo more closely, we depleted Tao-1 by
RNAi in Hpo-overexpressing cells and vice versa, and assayed
Yki-S168 phosphorylation. Tao-1 knockdown had no obvious
effect on overexpressed Hpo’s ability to induce Yki-S168 phos-
phorylation (lane 6, Figure 5A), whereas Hpo knockdown in
Tao-1-expressing cells abolished Tao-1’s ability to induce Yki-902 Developmental Cell 21, 896–906, November 15, 2011 ª2011 ElsS168 phosphorylation (lane 7, Figure 5A), suggesting a require-
ment of Hpo for Tao-1 to promote Yki-S168 phosphorylation.
Both Hpo and Tao-1 were required for basal Wts activity
because RNAi knockdown of either protein reduced Yki-S168
phosphorylation (lanes 8 and 9, respectively, Figure 5A; quantifi-
cation of Yki-S168 phosphorylation and a lighter exposure of
Figure 5A are shown in Figure S4).
We also investigated the epistatic relationship between Tao-1
and Hpo by using the Yki-Gal4 luciferase assay. Compared to
control cells, expression of Yki induced an 8-fold increase in
Yki-Gal4 activity (bar 2, Figure 5B). Co-overexpression of Sav,
Wts, and Tao-1 strongly repressed Yki-Gal4 activity back to
control levels (bar 4, Figure 5B). When these cells wereevier Inc.
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Figure 6. TAO1 Can Phosphorylate and Activate
MST2
(A) Phosphorylation of TAO1, TAO1-K57A (KD), MST2, and
MST2-K56R (KD) when immunoprecipitated from 293T
cells and incubated in the presence of g32P-ATP, either
individually or together. Molecular mass markers (kDa) are
indicated. Input immunoprecipitates (shown below) were
run on the same gel but split to align with congruent kinase
assay samples.
(B) Immunoblots of lysates prepared from 293T cells
transfected with the indicated plasmids and probed with
the indicated antibodies.
See also Figure S5.
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but significant, restoration in Yki activity (bar 5, Figure 5B), sug-
gesting that Hpo is important in relaying the signal to inhibit Yki
activity. By contrast, knockdown of Tao-1 using dsRNA in S2
cells expressing Sav, Wts, and Hpo had no significant effect
on their ability to repress Yki-Gal4 (bars 6 and 7, Figure 5B).
TAO1 Phosphorylates and Activates MST2
The results of genetic and biochemical experiments described
above favor the notion that Tao-1 functions upstream of Hpo.
Given that we show that Tao-1’s kinase activity was required
to restrict tissue growth and Yki activity, we hypothesized that
Tao-1 phosphorylates and activates Hpo (MST1/2 in mammals).
To explore this possibility, we used in vitro kinase assays to
determine whether TAO1 could stimulate phosphorylation of
MST2.
293T cells were transfected with plasmids encoding Myc-
tagged versions of TAO1, kinase-dead TAO1 (TAO1-K57A), or
kinase-dead MST2 (MST2-K56R). Proteins were immunoprecip-
itated individually using anti-Myc antibodies and incubated in the
presence of kinase buffer and g32P-ATP for 30 min. TAO1, but
not TAO1-K57A, exhibited strong autophosphorylation, whereas
MST2-K56R displayed a low level of basal phosphorylation,
possibly caused by dimerization with endogenous MST2, as
reported previously for MST1 (Glantschnig et al., 2002) (Fig-
ure 6A). When TAO1 and MST2-K56R were incubated together,
TAO1 induced substantial phosphorylation of MST2-K56R,
a result that was highly reproducible (Figures 6A and S5A).
TAO1-K57A was recovered by immunoprecipitation less effi-
ciently than TAO1 but clearly failed to induce phosphorylation
of MST2-K56R, suggesting that the observed TAO1-dependent
phosphorylation of MST2 was caused by TAO1 and not an
immunopurified protein (Figure 6A).
The aforementioned data are in accordance with our hypoth-
esis that Tao-1/TAO1 activates Hpo/MST1/2. To test this idea,
we transfected 293T cells with MST2 either alone or together
with TAO1 or TAO1-K57A and probed lysates from these cells
with antibodies that report MST2 activation. In the presence of
TAO1, but not TAO1-K57A, a robust increase in activation loop
phosphorylation of MST2 at residue T180 was observed (Fig-
ure 6B). This suggests that TAO1 enhances MST2 activity, and
is further illustrated by the observation that co-overexpression
of TAO1 with MST2 promotes strong phosphorylation on T12Developmeof MOBKL1A/B, a well-characterized substrate of MST1/2 (Fig-
ure 6B) (Praskova et al., 2008). Importantly, this is not due to
direct effects of TAO1 on MOBKL1A/B: phosphorylation of
MOBKL1A/B was catalyzed specifically by MST2, and not
TAO1, because phosphorylation of MOBKL1A/B T12 was not
observed when TAO1 was overexpressed either on its own or
together with inactive MST2 carrying a mutation at residue
T180 (MST2-T180A), an activation loop site that is required for
MST1/2 activity (Deng et al., 2003; Glantschnig et al., 2002)
(Figures S5B and S5C).
DISCUSSION
Genetic and biochemical studies have pointed to the existence
of unidentified SWH pathway kinases. Among known SWH
pathway kinases, Wts phosphorylates and represses Yki,
whereas Hpo activates Wts by phosphorylating the other core
kinase cassette proteins, Wts, Sav, and Mats (Huang et al.,
2005; Pantalacci et al., 2003; Wu et al., 2003). Proteins that acti-
vate Hpo are less well defined. Using a D. melanogaster genetic
screen, we have identified the sterile 20-like kinase Tao-1 as
a SWH pathway protein. By modulating Tao-1 expression, we
uncovered a role for this kinase as a suppressor of epithelial
tissue growth during D. melanogaster development. Several
points of evidence have led us to propose that Tao-1 regulates
tissue growth by activating the core SWH pathway kinase
cassette: (1) tissue with reduced Tao-1 activity displayed several
phenotypic similarities to tissue mutant for members of the core
SWH pathway kinase cassette, including Yki hyperactivation; (2)
alterations in tissue size caused by altered SWHpathway activity
were modifiable by Tao-1 hemizygosity; and (3) Tao-1 overex-
pression activated the core SWH pathway kinase cassette.
Our observation that Tao-1 was necessary for Hpo overex-
pression to suppress tissue growth suggested that either Hpo
functions either upstream of Tao-1 or, alternatively, that Tao-1
was required to activate Hpo, even when Hpo is overexpressed.
We favor the latter scenario based on several biochemical
results: (1) Tao-1 overexpression requires Hpo to stimulate Wts
activity in Drosophila S2 cells, but the inverse relationship was
not observed; (2) human TAO1 stimulated phosphorylation of
the Hpo ortholog, MST2, in in vitro kinase assays; and (3)
TAO1 activated MST2 in human cultured cells. This model is
also in keeping with biochemical studies that showed thatntal Cell 21, 896–906, November 15, 2011 ª2011 Elsevier Inc. 903
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Tao-1 Regulates the SWH PathwayHpo/MST1/2 activate Wts/LATS1/2 by phosphorylating these
proteins directly, rather than via an intermediary kinase (Chan
et al., 2005; Wu et al., 2003).
Tao-1’s role as a SWH pathway kinase appears to be
conserved throughout evolution because one of its three human
homologs, TAO1, repressed YAP activity in a manner that was
reliant on the SWH pathway core kinase cassette and because
TAO1 was found to phosphorylate and activate MST2. To our
knowledge, this is the first described example of a sterile
20-like kinase family member phosphorylating another kinase
from this family. To help address the mechanism by which
TAO1 regulates MST2, it will be important to define the MST2
residue(s) that TAO1 phosphorylates.
Currently, it is unclear whether Tao-1’s ability to control the
SWH pathway is regulated or whether it is constitutively active.
Several upstream regulatory branches of the SWH pathway
have been identified in recent years and appear to regulate the
SWH pathway largely by impinging on the core kinase cassette.
Ft promotes Wts stability (Cho et al., 2006), whereas both Ft and
Crb regulate the levels and apical junctional localization of Ex
(Bennett and Harvey, 2006; Chen et al., 2010; Grzeschik et al.,
2010; Ling et al., 2010; Robinson et al., 2010; Silva et al., 2006;
Willecke et al., 2006). Lgl and aPKC have been proposed to influ-
ence SWH pathway activity by regulating the subcellular locali-
zation of Hpo and dRASSF (Grzeschik et al., 2010). Kibra, Ex,
and Mer can interact with members of the core kinase cassette,
recruit Hpo to the plasma membrane, and induce activation of
Hpo and Wts (Baumgartner et al., 2010; Genevet et al., 2010;
Yu et al., 2010). Given that we found no evidence of physical
interactions between Tao-1 and several upstream SWHpathway
proteins (e.g., Kibra, Ex, and Mer; data not shown), biochemical
studies aimed at identifying Tao-1-interacting proteins are likely
to shed light on the question of Tao-1 regulation.
Interestingly, Tao-1 has been shown to regulate microtubule
polymerization at the cell cortex in both D. melanogaster and
mammalian cells (Liu et al., 2010; Timm et al., 2003). At present
there is no evidence to suggest that Tao-1’s abilities to regulate
SWH pathway-dependent tissue growth and microtubule
stability are in any way linked. However, it is interesting to note
that mechanical tension has been shown to regulate microtubule
polymerization at the cell cortex (Foethke et al., 2009; Janson
et al., 2003), and has been hypothesized to regulate tissue
growth (Aegerter-Wilmsen et al., 2007; Hufnagel et al., 2007)
and the SWH pathway (Grusche et al., 2010). Therefore, it is
tempting to speculate that Tao-1/TAO1 kinases could act as
a point of convergence between mechanical tension, the SWH
pathway, and control of tissue growth.
We have shown that Tao-1’s SWH pathway regulatory func-
tion is conserved in mammalian cells. It will be important to
extend these findings to determine whether the TAO1, 2, and 3
kinases control the growth of mammalian tissues. In addition,
given that SWH pathway activity is subverted at a high frequency
in many human tumor types, it raises the possibility that TAO1, 2,
and 3 function as tumor suppressor genes. According to the
COSMIC and Tumorscape databases, TAO1, 2, and 3 do not
appear to be mutated or deleted at a high frequency in the
tumors that were surveyed. However, based on our finding that
Tao-1 controls SWH pathway-dependent tissue growth, a closer
examination of the potential tumor suppressor function of human904 Developmental Cell 21, 896–906, November 15, 2011 ª2011 ElsTAO kinases is warranted, particularly in cancers that are known
to exhibit enhanced YAP activity.
EXPERIMENTAL PROCEDURES
Immunofluorescence
Primary antibodies were specific for b-galactosidase (Sigma-Aldrich), Cubitus
Interruptus, and Discs Large (both Developmental Studies Hybridoma Bank).
Anti-rat and anti-mouse secondary antibodies were from Invitrogen. Tissues
were stained as in Milton et al. (2010).
Quantification of Wing Size
Wings from female adult flies were reared at 29C, 25C, or 18C, and either
total wing area or the posterior compartment was quantified using Adobe Pho-
toshop. The mean and SEM values of wing area were determined with Graph-
Pad Prism. For statistical analysis, genotypes were compared using unpaired
Student’s t tests. p values <0.05 were considered significant.
Quantitative Real-Time PCR
RNAwas extracted from eye and wing imaginal discs or whole larvae by TRIzol
(Invitrogen), and used to generate cDNA with SuperScript III (Invitrogen).
Quantitative PCR reactions were analyzed on Applied Biosystems StepOne-
Plus software with Fast SYBR Green Master Mix (Applied Biosystems) and
primers designed to detect ex and Actin 5C mRNA as in Bennett and Harvey
(2006) and Harvey et al. (2008).
Luciferase Assays
Yki-Gal4 luciferase assays were performed in S2 cells transfected with plas-
mids and/or dsRNA using Cellfectin as described in Huang et al. (2005) and
Zhang et al. (2011). YAP/TEAD2 luciferase assays in 293T cells were per-
formed as described in Zhang et al. (2009). After 24 or 36 hr, cells were lysed,
and luciferase activity was recorded using the Dual-Luciferase Reporter Assay
System (Promega).
Immunoblotting
S2 cells or 293T cells were transfected with the indicated plasmids, lysed after
48 hr, subjected to SDS-PAGE, and transferred to PVDF (Millipore).
Membranes were immunoblotted with antibodies specific for TAO1 (S. Taylor)
(Westhorpe et al., 2010), YAP, MST2, phospho-T180-MST2 (all Cell Signaling),
MOBKL1A/B, phospho-T12-MOBKL1A/B (both J. Avruch) (Praskova et al.,
2008), Tubulin (Sigma-Aldrich), phospho-S168-Yki (D. Pan) (Dong et al.,
2007), HA tag (Roche), and Myc-tag (Santa Cruz Biotechnology).
Soft Agar Assays
Soft agar assays were performed in human MCF10A cells. Cells were trans-
fected with siGENOME SMARTpool NT1, siTAO1, or siYAP (for oligo
sequences for siRNA and dsRNA, see Supplemental Experimental Proce-
dures) and incubated for 36 hr. Cells were then trypsinized, seeded in
0.375% agarose in flat 96-well plates that were coated in 0.75% agarose,
and incubated for 4 days. alamarBlue (Invitrogen) was added to each well,
incubated overnight, and fluorescence was read using a POLARstar OPTIMA
(BMG Labtech) at 540/610 nm.
Kinase Assays
293T cells were transfected with TAO1 (Westhorpe et al., 2010), MST2, MST2-
K56R (Callus et al., 2006), TAO1-K57A, or MST2-K56R, T180A plasmids. Two
days after transfection, cells were lysed in DISC lysis buffer (150 mM NaCl,
2 mM EDTA, 1% Triton X-100, 10% glycerol, and 20 mM Tris [pH 7.5],
10 mM NaF, 2 mM Na pyrophosphate, 5 mM b-glycerophosphate, and Phos-
STOP phosphatase inhibitor cocktail [Roche] and Complete Mini protease
inhibitor cocktail [Roche]) and immunoprecipitated using anti-Myc (9E10;
Santa Cruz Biotechnology) and protein G-Sepharose (GE Healthcare). Equiv-
alent amounts of immunoprecipitates were divided into the combinations
noted in the figure legend in kinase buffer (50 mM HEPES [pH 7.4], 10 mM
MgCl2, 1 mM DTT, 10% glycerol, 1 mM EDTA, 1 mM EGTA, 100 mM NaCl,
1 mM NaF, 5 mM b-glycerophosphate, 100 mM ATP, PhosSTOP phosphatase
inhibitor cocktail, and Complete Mini protease inhibitor cocktail). A total ofevier Inc.
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Tao-1 Regulates the SWH Pathway5 mCi g32P-ATP (PerkinElmer) was added to each sample and incubated at
30C for 15 or 30 min as in Callus et al. (2006). The reaction was stopped by
the addition of 53 protein loading buffer, boiled at 95C, and subjected to
SDS-PAGE. Gels were dried and exposed to a Phosphorimager screen
(Molecular Dynamic) and analyzed using the Typhoon Trio Phosphorimager
and ImageQuant software (GE Healthcare) (Jastrzebski et al., 2011).SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
devcel.2011.09.012.
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